Loading clinical trials...
Loading clinical trials...
Subjects who completed ZA-003 were eligible to receive an additional year of treatment in this extension study.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Repros Therapeutics Inc.
NCT00911586 · Male Hypogonadism, Primary Hypogonadism, and more
NCT00467870 · Hypogonadism, Primary Hypogonadism, and more
NCT01739595 · Secondary Hypogonadism
NCT01993225 · Secondary Hypogonadism
NCT01270841 · Secondary Hypogonadism
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama
Medial Affiliated Research Center, Inc.
Huntsville, Alabama
Northern California Research Corp
Carmichael, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions